首页> 美国卫生研究院文献>Scientific Reports >Validating Antibodies for Quantitative Western Blot Measurements with Microwestern Array
【2h】

Validating Antibodies for Quantitative Western Blot Measurements with Microwestern Array

机译:使用Microwestern阵列验证用于定量Western印迹测量的抗体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fluorescence-based western blots are quantitative in principal, but require determining linear range for each antibody. Here, we use microwestern array to rapidly evaluate suitable conditions for quantitative western blotting, with up to 192 antibody/dilution/replicate combinations on a single standard size gel with a seven-point, two-fold lysate dilution series (~100-fold range). Pilot experiments demonstrate a high proportion of investigated antibodies (17/24) are suitable for quantitative use; however this sample of antibodies is not yet comprehensive across companies, molecular weights, and other important antibody properties, so the ubiquity of this property cannot yet be determined. In some cases microwestern struggled with higher molecular weight membrane proteins, so the technique may not be uniformly applicable to all validation tasks. Linear range for all validated antibodies is at least 8-fold, and up to two orders of magnitude. Phospho-specific and total antibodies do not have discernable trend differences in linear range or limit of detection. Total antibodies generally required higher working concentrations, but more comprehensive antibody panels are required to better establish whether this trend is general or not. Importantly, we demonstrate that results from microwestern analyses scale to normal “macro” western for a subset of antibodies.
机译:基于荧光的蛋白质印迹原则上是定量的,但是需要确定每种抗体的线性范围。在这里,我们使用microwestern阵列来快速评估定量Western印迹的合适条件,在具有7点,2倍裂解物稀释系列(〜100倍范围)的单个标准尺寸凝胶上,最多可进行192种抗体/稀释/复制组合)。试点实验表明,有很大比例的被研究抗体(17/24)适合定量使用。但是,该抗体样本在公司,分子量和其他重要抗体特性之间尚不全面,因此尚无法确定该特性的普遍性。在某些情况下,microwestern与更高分子量的膜蛋白作斗争,因此该技术可能无法统一适用于所有验证任务。所有已验证抗体的线性范围至少为8倍,最高为两个数量级。磷酸特异性抗体和总抗体在线性范围或检测限内没有明显的趋势差异。总抗体通常需要较高的工作浓度,但需要更全面的抗体小组才能更好地确定这种趋势是否普遍。重要的是,我们证明了微量蛋白质分析的结果可将部分抗体的水平扩展至正常的“宏观”蛋白质免疫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号